Delivery Order SPE2DB25D3012-SPE2DB25FWZXT
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,238.54 to AmerisourceBergen Drug Corp for 90 tablets of Januvia 100 mg, a diabetes medication. The contract, issued on August 7, 2025, with an ultimate completion date of August 8, 2025, utilizes firm fixed pricing and represents a non-set-aside competitive procurement. Performance will take place at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,779.46 to AmerisourceBergen Drug Corp for Januvia 100 mg tablets (90-count supply) on August 8, 2025, with an ultimate completion date of August 11, 2025. This is a firm fixed price, non-set-aside contract for delivery to the vendor's corporate headquarters location in Conshohocken, Pennsylvania. The delivery order represents a single transaction within AmerisourceBergen's broader federal pharmaceutical supply relationship with...
- The Defense Logistics Agency awarded a delivery order valued at $1,273.37 to AmerisourceBergen Drug Corp for the supply of Januvia 100 mg tablets (90-count units) on September 9, 2025, with completion scheduled for September 10, 2025. This competitively awarded, firm fixed-price contract with no set-aside designation reflects a routine pharmaceutical procurement fulfilling military healthcare supply requirements. The work will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $2,717.61 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Januvia 100 mg tablets (90-count units). This firm fixed-price contract, which is a child award under a larger indefinite delivery vehicle, represents a competitively awarded non-set-aside delivery order with an ultimate completion date of September 4, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $2,701.62 delivery order to AmerisourceBergen Drug Corp for 90 tablets of Januvia 100 mg, a diabetes medication, on September 2, 2025, with completion by September 3, 2025. This firm fixed-price delivery order represents a non-set-aside, competitively awarded contract utilizing AmerisourceBergen's existing indefinite delivery vehicle with DLA. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Januvia 100 mg tablets (90-count packages) valued at $1,718.04. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of September 10, 2025, to be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single line item purchase under AmerisourceBergen's existing pharmaceutical supply relationship...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,182.92 for 90 tablets of Januvia 100 mg on July 30, 2025, with completion scheduled for July 31, 2025. This firm fixed price, non-set-aside contract is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as...
- The Defense Logistics Agency awarded a $7,401.38 delivery order to AmerisourceBergen Drug Corp for 1,000 tablets of Januvia 100 mg, with an ultimate completion date of July 23, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The product will be delivered to the contractor's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $17,220.29 for 90 tablets of Januvia 100 mg on July 23, 2025, with completion scheduled for July 24, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single pharmaceutical procurement action supporting federal medical supply needs....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,546.29 to AmerisourceBergen Drug Corp for the supply of 1,000 tablets of Januvia 100 mg, a diabetes medication. The contract was executed on August 5, 2025, with an ultimate completion date of August 6, 2025, and is structured as a firm fixed-price delivery order with no set-aside designation. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- SPE2DB25D3012Indefinite Delivery Contract
- SPE2DB25D3012-SPE2DB25FWZXTDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,273.37 to AmerisourceBergen Drug Corp for 90 tablets of Januvia 100 mg, a pharmaceutical product used in diabetes management. The contract, issued on September 10, 2025, with an ultimate completion date of September 11, 2025, utilizes firm fixed-price pricing with no set-aside designation, indicating competitive award. Performance will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. As a leading pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen Drug Corp serves as a critical federal vendor supplying a comprehensive range of pharmaceutical products, medical devices, and specialized healthcare commodities to support military and veteran healthcare systems worldwide. The company's federal contract portfolio demonstrates extensive experience fulfilling medical procurement requirements across multiple therapeutic domains through competitive award processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 9/10/25 |